医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
37期
77-77
,共1页
病理学%生物学%乳腺癌%预后
病理學%生物學%乳腺癌%預後
병이학%생물학%유선암%예후
Pathology%Biology%Breastcancer%Prognosis
目的：探讨乳腺癌患者的病理学和生物学特征以及与预后的相关性。方法选取本院乳腺癌患者99例，均开展病理学与生物学相关检测，总结患者临床特征，同时与预后状况进行比较。结果本组患者中淋巴管侵犯26例(26.3%)，AR表达率分别为43.5%(27/62)，c-erbB2表达率为41.3%(26/63)，淋巴管侵犯程度、AR、c-erbB2不同亚型者的生存率差异有统计学意义(<0.01)。结论巴结状况和c-erbB2表达是影响年轻乳腺癌患者预后的独立预后因素，AR可作为一种辅助预后因子。
目的：探討乳腺癌患者的病理學和生物學特徵以及與預後的相關性。方法選取本院乳腺癌患者99例，均開展病理學與生物學相關檢測，總結患者臨床特徵，同時與預後狀況進行比較。結果本組患者中淋巴管侵犯26例(26.3%)，AR錶達率分彆為43.5%(27/62)，c-erbB2錶達率為41.3%(26/63)，淋巴管侵犯程度、AR、c-erbB2不同亞型者的生存率差異有統計學意義(<0.01)。結論巴結狀況和c-erbB2錶達是影響年輕乳腺癌患者預後的獨立預後因素，AR可作為一種輔助預後因子。
목적：탐토유선암환자적병이학화생물학특정이급여예후적상관성。방법선취본원유선암환자99례，균개전병이학여생물학상관검측，총결환자림상특정，동시여예후상황진행비교。결과본조환자중림파관침범26례(26.3%)，AR표체솔분별위43.5%(27/62)，c-erbB2표체솔위41.3%(26/63)，림파관침범정도、AR、c-erbB2불동아형자적생존솔차이유통계학의의(<0.01)。결론파결상황화c-erbB2표체시영향년경유선암환자예후적독립예후인소，AR가작위일충보조예후인자。
Objective To investigate the cor elation between pathological breast cancer and biological characteristics and prognosis.Methods 99 cases of breast cancer patients in our hospital, were to car y out pathology and biology related detection, to summarize the clinical characteristics of patients with, at the same time compared with prognosis.Results In this group of patients in 26 cases (26.3%),theexpressionrate of AR was 43.5%(27/62),the expression rate of c-erb B2 was 41.3%(26/63),as tatistical y significant survival dif erences between lymphatic invasion degree,AR,dif erent subtypes of c -erbB2' ( <0.01).Conclusion Lymphnodestatus and Cerb B2 expression were independent prognostic factors of prognosis of young breast cancer patients, ARcanbeusedasanauxiliaryprognosticfactor.
